The International AIDS Vaccine Initiative (IAVI) and the Translational Health Sciences and Technology Institute (THSTI), a private entity of India's Department of Biotechnology, have agreed to establish, operate and fund an HIV vaccine design program in New Delhi, according to an IAVI statement. The IAVI-THSTI collaboration will capitalize on recent IAVI research isolating a pair of broadly neutralizing antibodies against HIV.

To read the IAVI statement, click here.